Date | Title |
---|---|
02 Dec 2022 |
IP Group plc Portfolio company funding round leads to £36m net fair value gain |
15 Nov 2022 |
IP Group plc Becomes most active investor in Australian university spin-outs |
31 Aug 2022 |
IP Group plc Portfolio company Istesso announces initiation of Phase 2b trial of lead drug MBS2320 |
30 Aug 2022 |
IP Group plc Recommended cash acquisition of portfolio company Diurnal Group plc by Neurocrine Biosciences, Inc |
03 Aug 2022 |
IP Group plc |
02 Aug 2022 |
IP Group plc |
22 Jun 2022 |
IP Group plc Launches ‘Kiko Ventures’ platform to deepen its support for transformative climate technology |
14 Jun 2022 |
IP Group plc |
26 Apr 2022 |
Blog |
11 Apr 2022 |
IP Group plc & Parkwalk IP Group plc & Parkwalk co-lead $11m (£8.4m) Series A round in GripAble |
Loadmore